FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

CDER Starting 2 Quality Management System Pilots

CDER announces two quality management system pilot projects to help inform an agency rating system.

Federal Register

Guide on Nitinol Device Non-Clinical Assessments

Federal Register notice: FDA makes available a final guidance entitled Technical Considerations for Non-Clinical Assessment of Medical Devices contain...

Federal Register

Guide on Device Biocompatibility Info in Submissions

Federal Register notice: FDA makes available a draft guidance entitled Select Updates for Biocompatibility of Certain Devices in Contact with Intact S...

Medical Devices

Many AI/ML Framework Comments Lack Evidence: Study

University of Oxford researchers find that many comments on an FDA framework for modifying artificial intelligence and machine learning-based software...

Human Drugs

See-Mode Tech AI Cleared for Vascular Scans

FDA clears a See-Mode Technologies 510(k) for its Augmented Vascular Analysis, a medical artificial intelligence software for automated analysis and r...

Biologics

AstraZeneca Vaccine Safety Info Slow Coming to FDA: Report

An anonymous source tells CNN that AstraZeneca took several weeks to deliver data to FDA on the Covid vaccine trial participant illness that led to a ...

Human Drugs

FDA Hides Product Names in Serious CAERS Reports: Survey

Consumer Reports says FDA has been inappropriately redacting product names from some dietary supplement adverse event reports covering hospitalization...

Merit Medical Paying $18 Million to Resolve Kickback Case

The Justice Department says Merit Medical Systems will pay $18 million to resolve a whistleblower complaint that it paid advertising kickbacks to heal...

Medical Devices

Livmor Wearable Halo AF Detection System Cleared

FDA clears a Livmor 510(k) for the Livmor Halo AF Detection System, a physician-prescribed wearable device that provides continuous monitoring of puls...

Human Drugs

Avoid NSAIDs in Pregnancy After 20 Weeks: FDA

FDA cautions against pregnant women using prescription or OTC NSAIDs after 20 weeks because they can lead to low amniotic fluid.